Ausgabe 12/2012
Inhalt (17 Artikel)
Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin’s lymphoma patients
Riguel J. Inaoka, Achim A. Jungbluth, Sacha Gnjatic, Erika Ritter, Nicole C. Hanson, Denise Frosina, Jodie Tassello, Leina Y. Etto, Adriana B. Bortoluzzo, Antonio C. Alves, Gisele W. B. Colleoni
A naturally processed HLA-DR-bound peptide from the IL-9 receptor alpha of HTLV-1-transformed T cells serves as a T helper epitope
Hiroya Kobayashi, Takumi Kumai, Satoshi Hayashi, Yoshinari Matsuda, Naoko Aoki, Keisuke Sato, Shoji Kimura, Esteban Celis
Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer
Raquibul Hannan, Huagang Zhang, Anu Wallecha, Reshma Singh, Laibin Liu, Patrice Cohen, Alan Alfieri, John Rothman, Chandan Guha
Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma
Miriam Alb, Christopher Sie, Christian Adam, Suzie Chen, Jürgen C. Becker, David Schrama
Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer
Liangrong Shi, Qi Zhou, Jun Wu, Mei Ji, Guojun Li, Jingting Jiang, Changping Wu
Phase II trial of hu14.18-IL2 for patients with metastatic melanoma
Mark R. Albertini, Jacquelyn A. Hank, Brian Gadbaw, Jordan Kostlevy, Jennifer Haldeman, Heidi Schalch, Jacek Gan, KyungMann Kim, Jens Eickhoff, Stephen D. Gillies, Paul M. Sondel
Mast cells impair the development of protective anti-tumor immunity
Anna Wasiuk, Dyana K. Dalton, William L. Schpero, Radu V. Stan, Jose R. Conejo-Garcia, Randolph J. Noelle
Analysis of pre-treatment markers predictive of treatment benefit for the therapeutic cancer vaccine MVA-5T4 (TroVax)
Richard Harrop, Peter Treasure, Jackie de Belin, Michelle Kelleher, Gemma Bolton, Stuart Naylor, William H. Shingler
Using the allergic immune system to target cancer: activity of IgE antibodies specific for human CD20 and MUC1
Pearline Zhaoying Teo, Paul J. Utz, Joseph A. Mollick
Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay
Yasuto Akiyama, Masaru Komiyama, Yoji Nakamura, Akira Iizuka, Chie Oshita, Akiko Kume, Masahiro Nogami, Haruo Miyata, Tadashi Ashizawa, Shusuke Yoshikawa, Yoshio Kiyohara, Ken Yamaguchi
EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells
Amélie Vézina, Rima Chokor, Borhane Annabi
Induction of T cell responses and recruitment of an inflammatory dendritic cell subset following tumor immunotherapy with Mycobacterium smegmatis
Fenella J. Rich, Sabine Kuhn, Evelyn J. Hyde, Jacquie L. Harper, Franca Ronchese, Joanna R. Kirman
Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo
Connie Jackaman, David Majewski, Simon A. Fox, Anna K. Nowak, Delia J. Nelson
Effective modulation of CD4+CD25+high regulatory T and NK cells in malignant patients by combination of interferon-α and interleukin-2
Guangxian Liu, Wuwei Yang, Mei Guo, Xiaoqing Liu, Naixiang Huang, Dingfeng Li, Zefei Jiang, Wenfeng Yang, Weijing Zhang, Hang Su, Zhiqing Liu, Tieqiang Liu, Dongmei Wang, Shan Huang, Bo Yao, Qiuhong Man, Lijuan Qiu, Xuedong Sun, Yuying Sun, Bing Liu
Clinical safety and pharmacological profile of the HLA-DR antibody 1D09C3 in patients with B cell chronic lymphocytic leukemia and lymphoma: results from a phase I study
Carmen D. Schweighofer, Armin Tuchscherer, Sabine Sperka, Thorsten Meyer, Benno Rattel, Sandra Stein, Semra Ismail, Thomas Elter, Peter Staib, Marcel Reiser, Michael Hallek
The new aspects of immunotherapy in prostate cancer
Mostafa Ghanei, Majid Shohrati, Amin Saburi
Vitamin D-binding protein-derived macrophage-activating factor, GcMAF, and prostate cancer
Matteo Bellone, Nicolò Rigamonti